Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy | MicrobiomeTrials← Back to trialsNCT07629635
Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-09-01Est. Completion: 2027-12
Enrollment target: 32 participants Locations- Columbia University Medical Center, New York, New York, United States
Other microbiome trials you might be interested in
Eye Pain
Approximately 20% of Veterans have a diagnosis of dry eye (DE) syndrome which is often accompanied by ocular pain that s…
Miami, United StatesCompleted Nov 30, 2024
Temporomandibular Disorder
Temporomandibular disorders (TMD) encompass a group of conditions involving the masticatory muscles, temporomandibular j…
Ridgeland, United StatesEst. completion Jan 1, 2027
Migraine
The purpose of this study is to assess the bioequivalence of an alternative ODT formulation (ODT2) versus the approved O…
Brussels, BelgiumEst. completion Aug 31, 2026